Literature DB >> 3978547

Ependymoblastoma. A reappraisal of a rare embryonal tumor.

S J Mørk, L J Rubinstein.   

Abstract

This article reviews the clinicopathologic features of 12 ependymoblastomas, including those of 7 previously unreported cases. The histologic characteristics included a high density of small to medium-sized neuroepithelial cells with a uniform cytologic appearance, frequent mitotic figures, and numerous diagnostic ependymal rosettes and tubules. Differentiation was restricted to glial precursor cells and to cells with the differentiating features of ependymal cells. Cytogenetically, the tumor cells with the differentiating hallmarks of ependymal cells but which have retained their mitotic activity were considered to be ependymoblasts. Many of the rosettes in the tumors were of the ependymoblastic type, but ependymal rosettes were also present. The absence of pleomorphism, giant cells, multinucleation and pseudopalisades, and the scanty proliferation of vascular endothelial cells are additional features that delineate this tumor from an anaplastic (malignant) ependymoma. The median age of the patients was 2 years. After surgical treatment the median survival time was 12 months. Because of the frequency of leptomeningeal involvement, whole neuraxis radiation should be considered.

Entities:  

Mesh:

Year:  1985        PMID: 3978547     DOI: 10.1002/1097-0142(19850401)55:7<1536::aid-cncr2820550721>3.0.co;2-a

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  16 in total

1.  An immunohistochemical study of neuropeptides and neuronal cytoskeletal proteins in the neuroepithelial component of a spontaneous murine ovarian teratoma. Primitive neuroepithelium displays immunoreactivity for neuropeptides and neuron-associated beta-tubulin isotype.

Authors:  D V Caccamo; M M Herman; A Frankfurter; C D Katsetos; V P Collins; L J Rubinstein
Journal:  Am J Pathol       Date:  1989-11       Impact factor: 4.307

2.  A paediatric supratentorial primitive neuroectodermal tumour associated with malignant astrocytic transformation and a clonal origin of both components.

Authors:  Susanne A Kuhn; Uwe-Karsten Hanisch; Kristian Ebmeier; Christian Beetz; Michael Brodhun; Rupert Reichart; Christian Ewald; Thomas Deufel; Rolf Kalff
Journal:  Neurosurg Rev       Date:  2007-02-27       Impact factor: 3.042

Review 3.  Cerebral primitive neuroectodermal tumors in childhood.

Authors:  T Tomita; D G McLone; M Yasue
Journal:  J Neurooncol       Date:  1988-11       Impact factor: 4.130

Review 4.  Ependymoblastoma: MR presentation. A case report and review of the literature.

Authors:  T A Dorsay; M J Rovira; V B Ho; J Kelley
Journal:  Pediatr Radiol       Date:  1995

5.  Anaplastic ependymomas: clinical features and tumour suppressor gene p53 analysis.

Authors:  T Tominaga; T Kayama; T Kumabe; Y Sonoda; T Yoshimoto
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

Review 6.  The correlation of neoplastic vulnerability with central neuroepithelial cytogeny and glioma differentiation.

Authors:  L J Rubinstein
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

7.  Outcome of 11 children with ependymoblastoma treated within the prospective HIT-trials between 1991 and 2006.

Authors:  Nicolas U Gerber; Katja von Hoff; André O von Bueren; Wiebke Treulieb; Monika Warmuth-Metz; Torsten Pietsch; Niels Soerensen; Andreas Faldum; Angela Emser; Paul G Schlegel; Frank Deinlein; Rolf-Dieter Kortmann; Stefan Rutkowski
Journal:  J Neurooncol       Date:  2011-02-11       Impact factor: 4.130

8.  Ependymoblastoma: a clinical review.

Authors:  L Cervoni; P Celli; G Trillo; R Caruso
Journal:  Neurosurg Rev       Date:  1995       Impact factor: 3.042

9.  The ultrastructure of the ependymoblastoma.

Authors:  L A Langford
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

10.  Primary intracranial ependymoblastoma presenting as spinal cord compression due to metastasis.

Authors:  P B Shyn; G A Campbell; F C Guinto; M J Crofford
Journal:  Childs Nerv Syst       Date:  1986       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.